Table 3.
Observation | Study design | Biomarkers | References |
---|---|---|---|
Wholegrain wheat consumption leads to lower basal CRP and sICAM3 as compared to refined wheat consumption, whereas increased inflammatory resilience was observed for multiple cytokines. | Refined wheat (n = 25) vs. wholegrain wheat (n = 25) intervention in 45–70 years old males and females with elevated cholesterol (>5 mmol/L) PhenFlex challenge test dynamics up to 4 h |
TNF-α#, IL-6#, IL-8#, IL-10#, CRP*, #, SAA#, sICAM1, sICAM3*, sVCAM1, P-selectin, E-selectin, Thrombomodulin | (70) |
No significant differences were observed in basal inflammatory state between lean and MetS subjects. Inflammatory resilience was reflected in diminished cytokine and oxylipin responses. | 4 week high-fat, high-caloric diet intervention (n = 10) in males between 35 and 65 years High fat challenge test dynamics up to 8 h |
CRP, SAA, IL-1β, IL-6, IL-8#a, IL-10, IL-12p70, IL-18, TNF-α, IFN-γ#b, C3, sICAM1#b, sVCAM1, adiponectin*#b, leptin*#b, resistin*#a9(S)-HODE, 13(S)-HODE, 11(S)-HETE#a, 12(S)-HETE#a, 9,10-DiHOME, 12,13-DiHOME, 19,20-DiHoPE*, #b, 8,9-DiHETrE, 11,12-DiHETrE, 14,15-DiHETrELeukocytes, lymphocytes#b, neutrophils#b, monocytes#b, eosinophils, basophils | (51) |
Fasting levels of immune cell attraction markers were modified with 4-week dark chocolate consumption. No difference between flavonol-enriched and normal dark chocolate. | 4-week dark chocolate consumption (n = 41) by males with age 45–70 years High fat challenge test dynamics up to 4 h |
CRP, SAA, IL-1β, IL-6#, IL-8#, TNF-α*#, sICAM1*#, sVCAM1#, E-selectin, P-selectin#, sICAM3*#, Thrombomodulin, vWFLeukocytes*#, lymphocytes#, monocytes#, neutrophils#, CD11bN#, CD62LN#, CD11cM#, CD11bM#, CD62L, , , | (87) |
Inflammatory resilience was found positively influenced by the anti-inflammatory mix | 5 week intervention with anti-inflammatory dietary mix (n = 36) of males aged 55–59 years High fat challenge test dynamics up to 6 h |
With proteomics profiling, the following markers were significantly changed: CD40#a, VCAM1*, #a, fibrinogen#a, EGFR#a, vWF#a, ACE#a and ICAM1#b, Il-18*#b, TNF RII#b, adiponectin#b, factor VII#b, CCL-22#b, β2-microglobulin#b | (67, 79) |
Markers that were statistically significantly affect by the intervention are shown in bold.
marks a difference in fasting levels,
indicates different postprandial challenge test levels,
indicates a different challenge response and
indicates different offset levels observed due to repeated measurements.